Related Experiment Video
Updated: Jul 20, 2026

08:09
Isolation of Rat Adipose Tissue Mesenchymal Stem Cells for Differentiation into Insulin-producing Cells
Published on: August 29, 2022
MafA differentiates rat intestinal cells into insulin-producing cells
Satoshi Nomura1, Takaaki Nakamura, Tetsuya Hashimoto
1Division of Endocrinology and Metabolism, Department of Medicine, Shiga University of Medical Science, Japan.
Biochemical and Biophysical Research Communications
|August 29, 2006
Summary
Basic leucine zipper transcription factor MafA overexpression in the intestine of diabetic rats induced new insulin production in intestinal cells. This approach successfully increased plasma insulin levels and reduced hyperglycemia in vivo.
Area of Science:
- Endocrinology
- Molecular Biology
- Gene Therapy
Background:
- The transcription factor MafA is essential for insulin gene expression in pancreatic beta cells.
- Investigating alternative sites for insulin production is crucial for diabetes treatment.
Purpose of the Study:
- To determine if MafA overexpression in the intestine can induce insulin production in small-intestinal epithelial cells.
- To evaluate the therapeutic potential of intestinal insulin production in vivo.
Main Methods:
- Adenovirus-mediated MafA gene transfer (Ad-MafA) was administered orally to streptozocin-induced diabetic rats.
- Insulin gene expression was analyzed using RT-PCR.
- Insulin protein levels were detected via immunohistochemical analysis.
- Plasma insulin levels and blood glucose were monitored.
Main Results:
- MafA gene expression was successfully induced in the intestinal tissue.
- Insulin gene and protein were detected in intestinal epithelial cells post-Ad-MafA administration.
- Oral Ad-MafA administration led to increased plasma insulin levels and ameliorated hyperglycemia in diabetic rats.
Conclusions:
- MafA overexpression in the intestine can reprogram intestinal epithelial cells to produce and release insulin.
- Intestinal insulin production represents a potential novel therapeutic strategy for managing diabetes.
